Nov 09, 2017 12:01 pm UTC| Business
Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is evaluating the safety and...
BeyondSpring Reports Third Quarter 2017 Operational and Financial Results
Nov 09, 2017 12:01 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a pipeline of innovative immuno-oncology...
Alio Gold Provides Third Quarter 2017 Update
Nov 09, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Nov. 09, 2017 -- Alio Gold Inc. (TSX:ALO) (NYSE AMERICAN:ALO) (“Alio Gold” or the “Company”), today reported its third quarter 2017 results. Production results were previously released on...
Lifetime Brands, Inc. Reports Third Quarter Financial Results
Nov 09, 2017 12:01 pm UTC| Business
GARDEN CITY, N.Y., Nov. 09, 2017 -- Lifetime Brands, Inc. (NasdaqGS:LCUT), a leading global provider of branded kitchenware, tableware and other products used in the home, today reported its financial results for the...
Brooks Automation Reports Fourth Quarter Results of Fiscal Year Ended September 30, 2017
Nov 09, 2017 12:01 pm UTC| Business
CHELMSFORD, Mass., Nov. 09, 2017 -- Brooks Automation, Inc. (Nasdaq:BRKS), a leading worldwide provider of automation and cryogenic solutions for multiple markets, including semiconductor manufacturing and life...
2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide
Nov 09, 2017 12:01 pm UTC| Business
BATON ROUGE, La., Nov. 09, 2017 -- Amedisys (NASDAQ:AMED), a leading healthcare at home company, today announced that 48 percent of its home health care centers across the country have been named to the 2017 HomeCare...
ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board
Nov 09, 2017 12:01 pm UTC| Business
Key Updates Dr. Thaddeus (Ted) Dryja, a pioneer in the field of retinal genetic diseases, joins the Company’s Scientific Advisory Board.Dr. Dryja will play a key strategic role in the development and advancement of...